Výsledky vyhledávání - "G P, Molhoek"

Arrhythmogenic right ventricular dysplasia as a possible cause of sudden cardiac death: a case report and clinical review

Autor: H M M, Al Hashimi, A J J, van Es, M A, Galjee, G P, Molhoek, P M J, Verhorst

Publikováno v: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 12(7-8)

Sudden cardiac death can be described as an unexplained natural death due to a cardiac cause. It occurs within a short period, one hour or less, after onset of symptoms in a person without any prior medical history. Among the many causes of unexplain

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fe6ccfec55ab4a8eceb15c99e5d7c666
https://pubmed.ncbi.nlm.nih.gov/25696360

Zobrazit plný text záznamu

Left atrial myxoma as a cause of stroke

Autor: H M M, Al Hashimi, A J, Wardeh, P M J, Verhorst, A J J, van Es, G P, Molhoek

Publikováno v: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 14(7-8)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c424b6b450e2e49c1603bc23fdb04ddf
https://pubmed.ncbi.nlm.nih.gov/25696652

Zobrazit plný text záznamu

Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction. Results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial

Autor: Karl-Ludwig Neuhaus, U. Tebbe, G. P. Molhoek, Uwe Zeymer, Rolf Schröder, Karl Wegscheider

Publikováno v: European Heart Journal. 22:769-775

Aims The purpose of this study was to validate ST segment resolution as a non-invasive marker for patency of the infarct-related artery 90 min after the start of streptokinase therapy in patients with acute myocardial infarction. Methods and Results

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffde98d27b66e2c83f9592cac0a45572
https://doi.org/10.1053/euhj.2000.2290

Zobrazit plný text záznamu

Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency: The GUSTO Enzyme Substudy

Autor: M. L. Simoons, M. Pfisterer, G. P. Molhoek, T. Baardman, W.Th. Hermens, Timo Lenderink, Gilles Grollier

Publikováno v: European Heart Journal. 17:237-246

BACKGROUND: The recent international GUSTO trial of 41,021 patients with acute myocardial infarction demonstrated improved 90-min infarct related artery patency as well as reduced mortality in patients treated with an accelerated regimen of tissue pl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5633dea93f7797544fd0c97d015ecd1
https://doi.org/10.1093/oxfordjournals.eurheartj.a014840

Zobrazit plný text záznamu

Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study

Autor: G. P. Molhoek, J.H. Ruiter, Trigt M. van, J. van Gelder, A. Pilmeyer, Nic J. G. M. Veeger, Adelita V. Ranchor, Martin E.W. Hemels, Ans C.P. Wiesfeld

Publikováno v: Europace, 10(3), 304-311. Oxford University Press

Aims To investigate the efficacy of preventive and antitachycardia pacing (ATP) in patients with symptomatic paroxysmal atrial. fibrillation (AF) without bradyarrhythmias.Methods and results In this randomized cross-over pilot study, we randomized 38

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29b0ed26965d2734150bb24316693e17
https://pubmed.ncbi.nlm.nih.gov/18245199

Zobrazit plný text záznamu

Autonomic and hemodynamic effects of a new selective dopamine agonist, CHF1035, in patients with chronic heart failure

Autor: G, Tjeerdsma, L M, van Wijk, G P, Molhoek, F, Boomsma, J, Haaksma, D J, van Veldhuisen

Publikováno v: Cardiovascular drugs and therapy. 15(2)

Dopamine agonists have been studied in chronic heart failure, but earlier reports with non-selective compounds demonstrated unfavourable long-term effects. CHF 1035 is an orally active, new selective dopamine agonist, primarily activating DA2- and al

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ea427786990d2ef0614926d8034b2e2e
https://pubmed.ncbi.nlm.nih.gov/11669407

Zobrazit plný text záznamu

Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial

Autor: K L, Neuhaus, G P, Molhoek, U, Zeymer, U, Tebbe, K, Wegscheider, R, Schröder, A, Camez, G J, Laarman, G M, Grollier, D J, Lok, H, Kuckuck, P, Lazarus

Publikováno v: Journal of the American College of Cardiology. 34(4)

The purpose of this study was to compare recombinant hirudin and heparin as adjuncts to streptokinase thrombolysis in patients with acute myocardial infarction (AMI).Experimental studies and previous small clinical trials suggest that specific thromb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ac0835686c2507443ab12d1d4980f8ba
https://pubmed.ncbi.nlm.nih.gov/10520777

Zobrazit plný text záznamu

Angiographic dose-finding study with r-hirudin (HBW 023) for the improvement of thrombolytic therapy with streptokinase (HIT-SK). Interim results

Autor: GertJan Laarman, P. Zijnen, Dirk J. Lok, L. H. Takens, C. M. Luz, D. P. Hertzberger, J. H. Kingma, A. H. Bosma, A. A. van den Bos, G. P. Molhoek

Publikováno v: European heart journal. 16

To evaluate the efficacy and safety of hirudin, a direct thrombin inhibitor, in patients with acute myocardial infarction, a dose-finding, angiography study rvas carried out. After a pilot phase in 10 patients treated with a bolus of 0·1 mg . kg−1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e748dfee9180c308d023d73f69d24bc3
https://pubmed.ncbi.nlm.nih.gov/8542870

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání